iSpecimen Inc.

ISPCNASDAQHealthcare● Active

$2.95

$-0.07(-2.32%)

Market Cap$409643

P/E Ratio—

52W High$127.2

52W Low$2.9

Avg Volume983K

Open$3.00

Beta1.62

Overview

iSpecimen Inc. (ISPC) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

ISPC · free cash flow · updated Jun 9, 2026

Core FCF metrics

ISPC · FCF · TTM · margin & CAGR

Free cash flow was −$4.2M for FY2025 (fiscal year ending 2025-12-31), up 48.9% year-over-year The FCF margin was -219.9%.

FY2025 Free Cash Flow−$4.2M▲ +48.9% YoY

Trailing 12M (TTM)−$6.5Mtrailing 4 quarters sum

FCF Margin-219.9%−$4.2M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

ISPC · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$4.2M(0M)−$4.2M▲ +48.9%-219.9%

FY2024−$8.3M(0M)−$8.3M▲ +21.4%-89.3%

FY2023−$5.8M(5M)−$10.6M▼ 17.1%-106.3%

FY2022−$5.8M(3M)−$9.0M▲ +23.0%-86.6%

FY2021−$10.7M(1M)−$11.7M▼ 741.6%-105.1%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

ISPC · P/FCF · FCF yield · FCF per share

iSpecimen Inc. (ISPC) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

ISPC · cash flow statement · operating / investing / financing

For FY2025, iSpecimen Inc. generated −$4.2M in operating cash flow and spent 0M in capital expenditures, yielding −$4.2M in free cash flow.

Operating Activities

−$4.2M

Cash from core business operations

2025-12-31

Investing Activities

−$1.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$10.2M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$4.2M) − |CapEx| (0M) = FCF (−$4.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

ISPC vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

iSpecimen Inc.YOU

ISPC

−$4.2M+48.9%-219.9%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

iSpecimen Inc. (ISPC) reported free cash flow of −$4.2M for FY2025 (fiscal year ending 2025-12-31), up 48.9% year-over-year. The FCF margin was -219.9%.

iSpecimen Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 8 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

ISPC free cash flow · 8 questions

iSpecimen Inc. free cash flow was −$4.2M for FY2025, up 48.9% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$6.5M.

ISPC free cash flowISPC FCFISPC FCF 2025ISPC free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · iSpecimen Inc. · iSpecimen Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026